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Abstract
Before analysis of DNA from ancient remains was possible, anthropologists studied evolution and migration 
patterns using data obtained from population genetic studies on modern populations combined with data 
obtained from morphological evaluations of ancient remains. Currently, DNA analysis of ancient popula-
tions is making a valuable contribution to these efforts. Researchers that perform ancient DNA analysis 
prefer to study polymorphisms on the Y chromosome or mitochondrial DNA because the results are easier 
to statistically evaluate. To evaluate polymorphisms on diploid genomes, which are more informative, only 
mutations that have been extensively examined in modern populations should be chosen.  The most exten-
sively evaluated mutations are those related to prevalent inherited disorders. As such, beta-thalassemia, 
sickle cell anemia, FVL mutation of globin and the factor V genes are good candidates for DNA studies in 
ancient  populations.  These  mutations  are  common  in  Anatolia,  host  to  many  civilizations  since  the 
Paleolithic period. This history makes Anatolia a good place for conducting research that could enhance 
our understanding of human evolution and migration patterns. (Turk J Hematol 2011; 28: 257-63)
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Özet
Antik örneklerden DNA elde edilebileceğinin anlaşılmasından önce antropologlar tarih öncesi insan 
kalıntılarından elde ettikleri bilgilere modern topluluklardan elde edilen populasyon genetiği bulgula-
rını da ekleyerek evrimsel süreçler ve göç yolları ile ilgili yoruma ulaşmaya çalışırlardı. Günümüzde 
antik topluluklar üzerinde gerçekleştirilebilen DNA analizleri antropologların bu çabasına büyük katkı 
sağlamaktadır. Uygulamadaki tüm güçlüklere rağmen sağlayacağı önemli bilgi nedeni ile antik DNA 
analizini uygulamayı seçen birçok bilimadamı istatistiksel olarak sonuçları daha rahat değerlendirildi-
ğinden öncelikle mitokondriyal DNA ve Y kromozomu üzerindeki farklılıklara odaklanmıştır. Bu eği-
limin  sebebi,  diploit  genom  üzerinde  bulunan  farklılıkların  daha  bilgilendirici  olmalarına  rağmen 
değerlendirme açısından birçok güçlüğü de beraberinde getirmesidir ve bu sorun ile başa çıkabilmek 
TJH-ARALIK-2011-4-crossref.indd   9 02.12.2011   10:13Introduction
After  Chinese  researchers  showed  that  DNA 
could  be  preserved  in  ancient  tissues  in  1980,  2 
subsequent studies were conducted: Higuchi stud-
ied Quagga (an extinct horse species) in 1984 and 
Paabo  reported  on  a  2400-year-old  mummy  in 
1985. These studies are considered the first ancient 
DNA studies and are acknowledged as the begin-
ning  of  a  new  era  [1-3].  Although  these  studies 
drew immediate interest in ancient DNA research 
among the scientific community, this novel field of 
study did not become popular until the advent of 
the  polymerase  chain  reaction  (PCR)  technique 
towards  the  end  of  the  1980s.  As  the  PCR  tech-
nique  facilitates  work  with  DNA  extracted  from 
ancient samples and enables ancient DNA research 
to be systematically performed, researchers quick-
ly became aware of the value of studying evolution 
based on ancient DNA [4,5]. As such, many ancient 
DNA studies have been conducted during the last 
25 years. 
Common to all ancient DNA studies is the chal-
lenge to obtain undamaged DNA due to the nature 
of  ancient  samples  [6-10].  The  quality  of  DNA  in 
ancient samples depends on environmental factors 
and the duration of exposure to them. DNA extract-
ed from ancient samples is both highly degraded 
and  contaminated  with  PCR  inhibitors  that  are 
abundant  in  soil;  therefore,  the  results  of  studies 
based  on  such  low-quality  samples  are  generally 
received with great skepticism [11]. As such, ancient 
DNA  laboratories  must  use  more  elaborate  mea-
sures  [12,13].  The  development  of  proper  proce-
dures is important for overcoming the challenges 
posed by ancient DNA analysis. The design of small 
fragments that contain point mutations has recently 
gained importance because it is known that only 
small  fragments  of  approximately  200  bp  can  be 
amplified from ancient DNA. 
Although  ancient  DNA  analysis  is  very  difficult 
and the possibility of obtaining significant results is 
low, interest in ancient DNA analysis continues to 
increase because the knowledge gained via such 
analysis has become indispensable in research on 
ecology and evolution. It has been common prac-
tice  to  gather  pieces  of  information  from  various 
fields  for  analysis  in  order  to  better  understand 
migration  patterns  and  evolutionary  stages.  For 
instance, anthropologists combine the knowledge 
gained  from  human  remains  and  what  is  known 
about  genetic  polymorphisms  in  contemporary 
populations to study human history. As systematic 
ancient  DNA  analysis  is  now  possible,  data  from 
studies on mutations in ancient human populations 
can  make  a  unique  contribution  to  the  field’s 
knowledge base only if such mutations have been 
thoroughly studied in modern populations [14,15]. 
Human remains in biological anthropology 
Anthropologists  study  human  biological  evolu-
tionary processes and examine anthropogenic dif-
ferences between living populations. When a skel-
eton is evaluated, not only will information regard-
ing  its  age  and  gender  be  discerned,  but  crucial 
knowledge  regarding  its  dietary  habits,  cause  of 
death,  and  health  will  also  be  determined.  The 
knowledge gained from individual samples is then 
evaluated in order to reach conclusions regarding 
their  population.  Such  data,  along  with  data  col-
lected from the same archeological sites regarding 
the culture and religion of that particular period can 
be somewhat simulated. Finally, every population 
examined  in  detail  is  compared  with  another,  in 
terms of their relationship, which helps researchers 
understand the dynamics of a particular period [16]. 
için modern topluluklarda derinlemesine analiz edilmiş mutasyonların tercih edilmesi gerekmektedir. 
Günümüzde en iyi değerlendirilmiş mutasyonlar yaygın görülen belli kalıtsal bozukluklarla ilişkilendi-
rilmiş olanlardır. Bunların içerisinde hematolojik bozukluklar ile ilişkilendirilen ve evrimsel süreçleri 
son derece iyi bilinen globin ve faktör V genlerinde yer alan beta talasemi, orak hücre anemisi ve FVL 
mutasyonları iyi adaylardır. Bu yüzden paleolitik dönemden itibaren birçok farklı kültüre evsahipliği 
yapan ve adı geçen mutasyonların yüksek prevalanslarda gözlendiği Anadolu, insan evrimi ve göç yol-
larının anlaşılması için eşsiz bir kaynak sunmaktadır. (Turk J Hematol 2011; 28: 257-63)
Anahtar  kelimeler:  DNA, populasyon genetiği, moleküler antropoloji, Factor V, beta-thalassemia, 
orak hücre anemi, Anadolu
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is the examination of the signs indicative of a skel-
eton’s  state  of  health;  however,  this  can  only  be 
determined if there are obvious signs left in bones 
or teeth [17-19]. When skeletal signs of morbidity 
are  detected,  its  origin,  its  distribution  within  the 
skeleton’s  group  or  modern  populations,  and  the 
skeleton’s dietary habits can be evaluated. Moreover, 
if the morbidity being studied is inherited, genetic 
links between human populations and evolutionary 
pressures that have played a role in the inheritance 
of the mutation up to the present can also be includ-
ed in the analysis. 
Although it provides valuable data, evaluation of 
phenotypes reflected in bones is difficult for anthro-
pologists. The most common difficulty for anthro-
pologists is that bone pathologies may also be due 
to  environmental  conditions  that  trigger  clinical 
signs. Porotic hyperostosis related to iron deficien-
cy anemia can also occur in other types of non-
inherited  anemias  in  agricultural  populations  in 
which  the  consumption  of  fat  is  low,  but  that  of 
grain is high [20]. This is why DNA analysis is neces-
sary for understanding whether or not a condition is 
inherited [21]. DNA analysis is crucial for pinpoint-
ing a disease-related mutation in an ancient popula-
tion, comparing this information with that of other 
ancient  and  modern  populations  from  the  same 
geographic region, evaluating the genetic similarity 
of  these  populations,  and  for  understanding  the 
environmental pressures that played a role in pre-
serving the mutation. Studying the spread of muta-
tions in the past and their modern prevalence make 
it possible to understand how they have been sub-
jected  to  natural  selection  and  to  gather  data  on 
migration patterns [15]. 
Molecular anthropology and inherited 
hematologic disorders
Molecular anthropology uses anthropologic and 
molecular genetic data to discern the evolutionary 
link between ancient and modern populations, and 
to  determine  human  migration  patterns.  For 
instance, examination of DNA polymorphisms is a 
common  method  used  to  study  the  history  of 
human evolution. The entire genome has polymor-
phic sites, but use of polymorphism data obtained 
from the chromosome Y and mitochondrial DNA is 
preferred.  Although  the  diploid  genome  provides 
more information when interpreted accurately, as 
interpretation of data obtained from diploid genome 
studies is difficult researchers are reluctant to use 
diploid genome data in population genetics [22]. To 
facilitate  interpretation  of  diploid  genome  study 
results  it  is  crucial  to  choose  mutations  whose 
molecular genetics and evolutionary stages are well 
known.
According to modern genetics theory there are 5 
factors  that  can  affect  gene  frequency:  selection, 
mutation,  genetic  drift,  gene  flow,  and  selective 
mating. As such, any study that aims to determine 
the spread of an allele should consider all 5 factors. 
An allele concerning a particular situation can be 
among the population founders, can be indepen-
dently  introduced  from  outside  the  population 
structure after the population has been established, 
or can be mixed in the population structure due to 
genetic  contact  with  a  neighboring  population.  If 
the mutation frequently occurs in different popula-
tions, its origin can be determined by evaluating the 
mutation and simultaneously inherited haplotypes. 
Such genetic variations as haplotypes provide valu-
able  information  for  tracing  migration  patterns, 
determining an individuals’ geographic origin, and 
establishing connections within populations [23]. 
The spread of genetic variations, some of which 
cause genetic diseases, varies worldwide; however, 
some similarities can be observed in the frequency 
of  these  mutations  and  their  haplotypes  within 
populations that interacted during a particular peri-
od  and/or  shared  geographic  locations  [24].  As 
such,  studies  on  the  frequency  and  carriage  per-
centage of particular mutations can provide addi-
tional data concerning connections between popu-
lations [25]. Moreover, the prevalence of a specific 
disease-related  mutation  in  populations  can  be 
determined and how the processes of population 
genetics  might  possibly  have  affected  the  preva-
lence can be examined. Haplotypes carried with a 
mutation are used to identify such as factors migra-
tion, genetic drift, and natural selection that affected 
the frequency of the mutation. Not only does haplo-
type  analysis  frequently  enable  the  history  of  a 
mutation to be reconstructed, it also provides infor-
mation  about  how  often  and  when  its  frequency 
was altered, and in which populations the mutation 
first  existed  [26].  Accordingly,  despite  its  symp-
toms-including the risk of mortality-the widespread 
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ous  genetic  factors  in  different  populations  [27]; 
therefore,  mutations  that  have  been  extensively 
studied in modern populations must also be exam-
ined in ancient populations, as they can provide 
useful  data  on  genetic  relationships.  The  muta-
tions  that  appeal  to  research  most  are  generally 
those  related  to  certain  genetic  disorders  and 
those that maintain their frequency despite their 
negative affects on health. Thus, beta-thalassemia, 
sickle cell anemia, and Factor V G1691A (Leiden) 
(FVL) mutations are examples of the most exten-
sively studied mutations [28-30]. 
The  malaria  hypothesis  is  considered  to  be  a 
crucial starting point in determining the factors that 
affect the prevalence of hemoglobinopathies, com-
mon and heterogeneous worldwide [26]. The geo-
graphic distribution of malaria and hemoglobinopa-
thies overlap to a great extent. It is likely that the 
malaria parasite has coexisted with modern humans 
for  ages;  however,  malaria  is  thought  to  have 
become  widespread  approximately  10,000  years 
ago in Levant and in Asia. The high prevalence of 
this parasite is thought to have originated with the 
development of agriculture. 
Agricultural activities first put an end to the scar-
city of food, which was the most important factor 
controlling  population  growth.  Consequently,  this 
resulted  in  rapid  population  growth  and  diseases 
replaced the scarcity of food as the primary factor 
controlling population growth. While creating space 
for agricultural activities humans destroyed vegeta-
tion and fauna, and altered the balance of the envi-
ronment. This process caused many mammals to 
become  extinct  and  many  parasites  to  lose  their 
hosts; as a result, such parasites began infecting the 
expanding human population [27]. In populations 
affected by malaria, a high frequency of hemoglo-
binopathies-including sickle cell anemia and thalas-
semia-has  been  noted  [31,32].  It  is  plausible  to 
conclude that their heterozygous carriers are resis-
tant to malaria; however, although there is consider-
able geographic overlap between these mutations 
and  malaria,  in  the  case  of  beta-thalassemia  the 
correlation is not as straightforward as in the case of 
sickle cell anemia [33]. Beta-thalassemia is wide-
spread in subtropical malarial, Mediterranean, and 
Middle  Eastern  regions;  however,  it  also  exists  in 
some non-malarial regions. As such, the existence 
of  another  evolutionary  process  alongside  the 
advantage brought by heterozygocity appears to be 
likely. 
Another well known mutation, factor V Leiden 
(FVL),  which  increases  the  risk  of  thrombosis 
80-fold  when  homozygotic,  is  a  common  mono-
genic disorder. Its worldwide distribution is highly 
heterogeneous  and  exhibits  remarkable  ethnic 
diversity. While polymorphism ranging from 1%-8.5% 
is  present  in  Europeans,  Jews,  Israel-Arabs,  and 
Indians, it is non-existent in African blacks, Chinese, 
Japanese, and indigenous South Americans [34-38]. 
Limited and ethnic distribution of FVL suggests that 
the mutation originated from a single source, most 
probably Europeans or Neolithic farmers along the 
migratory path. 
During  the  Neolithic  period  about  10,000  years 
ago  farming  spread  to  Northern  Europe  from  the 
Middle East. The distribution of FVL followed a simi-
lar pattern, suggesting that the distribution is due to 
Neolithic  migration.  Furthermore,  the  army  of 
Alexander the Great is thought to have contributed 
to the distribution of FVL [39]. Evolutionary hypoth-
eses regarding the distribution of FVL suggest the 
possibility  that  heterozygosity  may  have  been  a 
selective  advantage.  In  the  past,  deaths  resulting 
from  sepsis  and  bleeding  during  pregnancy  and 
birth accounted for 10% of all deaths. It seems high-
ly plausible that a mutation preventing bleeding may 
have provided a selective advantage [40]. Haplotype 
analysis of FVL suggests that the founder effect may 
have influenced distribution of the mutation and the 
advent of the mutation can be traced back 21,000 
years. The origin of Caucasians among which the 
mutation  is  prevalent  can  be  traced  back  40,000 
years. This historical fact coincides with the claim 
that  FVL  mutation  first  occurred  in  a  Caucasian 
ancestor 21,000 years ago [41]. A study on popula-
tion genetics of the mutation shows that during the 
Neolithic  period  FVL  in  Europe  probably  spread 
from Anatolia (Turkey) [42].
Why Anatolia?
Anatolia,  due  to  its  favorable  geographic  and 
strategic  location,  has  been  home  to  numerous 
civilizations  since  the  Paleolithic  period  [43].  Its 
geographic location-bridging continents-has been 
an  important  passage  for  numerous  species, 
including humans. This has made Anatolia a pre-
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many  advantages  for  its  inhabitants,  it  was  also 
suitable for malaria due to its wetlands. This result-
ed  in  a  high  frequency  of  beta-thalassemia  and 
sickle cell anemia, which in turn provided protec-
tion  against  malarial  epidemics,  once  a  severe 
threat  in  the  Mediterranean  region  [43-50].  FVL, 
another  mutation  that  probably  originated  in 
Anatolia 21,000 years ago, is also highly prevalent 
in this region [44,45].
In  Anatolia  a  number  of  mutations  that  have 
been extensively examined, in terms of molecular 
genetics and population genetics, occur frequently, 
offering a uniquely valuable source for identifying 
genetic  markers  in  ancient  populations. 
Distinguishing and analyzing the layers of popula-
tion history in this region in which various popula-
tions have been fighting, immigrating, trading and 
praying to different Gods for centuries is a challeng-
ing task. As such, molecular techniques can aid in 
the analysis of ancient communities; however, only 
a few studies have examined genetic diseases at 
the molecular level in ancient populations, though 
they reported valuable results. 
In 1995 Filon performed DNA analysis of a child’s 
skeleton  that  was  thought  to  have  had  porotic 
hyperostosis  due  to  iron  deficiency  anemia  and 
reported the existence of beta-thalassemia-related 
mutation. As a result, he was able to show that data 
related to ancient populations, which earlier could 
not be obtained, could be obtained via DNA experi-
ments [21,49]. The same year Beraud-Colomb et al. 
extracted DNA from skeletal remains belonging to 
different  years  and  evaluated  various  polymor-
phisms on the globin gene using skeletal DNA [15]. 
The only similar study in Anatolia was performed by 
our group in 2009 using 3000-year-old Urartian tooth 
samples  excavated  from  a  site  in  Anatolia.  DNA 
samples extracted from these teeth were screened 
using real time PCR to detect FVL mutation and 1 of 
the samples, which was previously determined to 
be male, was heterozygotic [51,52]. 
Conclusion
Anatolia is a fertile land suitable for agriculture 
and  has  always  appealed  to  scientists  due  to  the 
richness of its biodiversity and the vast number of its 
ancient populations. A significant number of histori-
cal excavations in this region have been performed 
by non-Turkish scientists, and therefore DNA analy-
sis  on  ancient  materials  have  been  conducted 
abroad  [53,54];  however,  we  think  it  is  important 
that  such  results  be  evaluated  by  scientists  with 
knowledge about the modern Anatolian population. 
Mutations with a high frequency in modern popula-
tions have a heterogeneous distribution in Anatolia 
as well as in other parts of the world; therefore, for 
the study of sickle cell anemia mutation in ancient 
populations,  excavations  closer  to  Mersin,  Tarsus, 
Adana, and Hatay, Anatolian regions in which the 
mutation currently has a high frequency, will increase 
the probability of identifying this mutation and make 
it possible to compare its frequency in ancient and 
modern  populations.  As  such,  additional  research 
may provide an abundance of data on the genetic 
background of Anatolian populations.
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